KatzUZandman-GoddardG. Drug-induced lupus: an update. Autoimmun Rev2010; 10: 46–50.
2.
NowakMCarrasquilloJYarboroC. A pilot study of the use of [2-[18F]-fluoro-2-deoxy-D-glucose—PET] to assess the distribution of activated lymphocytes in patients with systemic lupus erythematosus. Arthritis Rheum2004; 50: 1233–1238.
3.
CurielRAkinEBeaulieuGDePalmaLHashefiM. PET/CT imaging in systemic lupus erythematosus. Ann N Y Acad Sci2011; 1228: 71–80.
4.
KitsanouMAndreopoulouEBaiMElisafMDrososA. Extensive lymphadenopathy as the first clinical manifestation in systemic lupus erythematosus. Lupus2000; 9: 140–143.